» Articles » PMID: 33841749

Metabolomics Reveals Sex-specific Metabolic Shifts and Predicts the Duration from Positive to Negative in Non-severe COVID-19 Patients During Recovery Process

Overview
Specialty Biotechnology
Date 2021 Apr 12
PMID 33841749
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Metabolic profiling in COVID-19 patients has been associated with disease severity, but there is no report on sex-specific metabolic changes in discharged survivors. Herein we used an integrated approach of LC-MS-and GC-MS-based untargeted metabolomics to analyze plasma metabolic characteristics in men and women with non-severe COVID-19 at both acute period and 30 days after discharge. The results demonstrate that metabolic alterations in plasma of COVID-19 patients during the recovery and rehabilitation process were presented in a sex specific manner. Overall, the levels of most metabolites were increased in COVID-19 patients after the cure relative to acute period. The major plasma metabolic changes were identified including fatty acids in men and glycerophosphocholines and carbohydrates in women. In addition, we found that women had shorter length of hospitalization than men and metabolic characteristics may contribute to predict the duration from positive to negative in non-severe COVID-19 patients. Collectively, this study shed light on sex-specific metabolic shifts in non-severe COVID-19 patients during the recovery process, suggesting a sex bias in prognostic and therapeutic evaluations based on metabolic profiling.

Citing Articles

Plasma metabolomics profiles indicate sex differences of lipid metabolism in patients with Parkinson's disease.

Ling Hu , Huang Y, Wei Y, Li T, Ke W, Chen G Sci Rep. 2024; 14(1):31262.

PMID: 39732876 PMC: 11682129. DOI: 10.1038/s41598-024-82674-3.


Metabolomics-directed nanotechnology in viral diseases management: COVID-19 a case study.

El-Derany M, Hanna D, Youshia J, Elmowafy E, Farag M, Azab S Pharmacol Rep. 2023; 75(5):1045-1065.

PMID: 37587394 PMC: 10539420. DOI: 10.1007/s43440-023-00517-w.


Integrated Metabolic and Inflammatory Signatures Associated with Severity of, Fatality of, and Recovery from COVID-19.

Gardinassi L, do Prado Servian C, Lima G, Dos Anjos D, Gomes Junior A, Guilarde A Microbiol Spectr. 2023; :e0219422.

PMID: 36852984 PMC: 10100880. DOI: 10.1128/spectrum.02194-22.


Spectroscopic methods for COVID-19 detection and early diagnosis.

Bedair A, Okasha K, Mansour F Virol J. 2022; 19(1):152.

PMID: 36138463 PMC: 9502632. DOI: 10.1186/s12985-022-01867-2.


Serum metabolomic abnormalities in survivors of non-severe COVID-19.

Li F, Fu L, Liu X, Liu X, Liang Y, Lv Y Heliyon. 2022; 8(9):e10473.

PMID: 36065322 PMC: 9433334. DOI: 10.1016/j.heliyon.2022.e10473.


References
1.
Ambade V . Biochemical rationale for hypoalbuminemia in COVID-19 patients. J Med Virol. 2020; 93(3):1207-1209. PMC: 7537253. DOI: 10.1002/jmv.26542. View

2.
Joshi J, Joshi B, Rochford I, Rayees S, Akhter M, Baweja S . SPHK2-Generated S1P in CD11b Macrophages Blocks STING to Suppress the Inflammatory Function of Alveolar Macrophages. Cell Rep. 2020; 30(12):4096-4109.e5. PMC: 7170050. DOI: 10.1016/j.celrep.2020.02.112. View

3.
Ojala P, Hirvonen T, Hermansson M, Somerharju P, Parkkinen J . Acyl chain-dependent effect of lysophosphatidylcholine on human neutrophils. J Leukoc Biol. 2007; 82(6):1501-9. DOI: 10.1189/jlb.0507292. View

4.
Qian J, Zhao L, Ye R, Li X, Liu Y . Age-dependent Gender Differences in COVID-19 in Mainland China: Comparative Study. Clin Infect Dis. 2020; 71(9):2488-2494. PMC: 7314154. DOI: 10.1093/cid/ciaa683. View

5.
Prihandoko R, Kaur D, Wiegman C, Alvarez-Curto E, Donovan C, Chachi L . Pathophysiological regulation of lung function by the free fatty acid receptor FFA4. Sci Transl Med. 2020; 12(557). DOI: 10.1126/scitranslmed.aaw9009. View